Chugai Files Regulatory Application in Japan for S...
Category : Approval/Launch 22 June 2026Chugai Seeks Approval for New IgA Nephropathy Treatment Chugai Pharmaceutical has announced the sub...
Chugai Seeks Approval for New IgA Nephropathy Treatment Chugai Pharmaceutical has announced the sub...
Merck, known as MSD outside the United States and Canada, has announced that the U.S. Food and Drug...
TREMFYA Receives New Approval for Inflammatory Bowel Diseases in Egypt Johnson & Johnson has an...
AbbVie Expands the Role of Aquipta in Migraine Care Across Europe AbbVie has announced that the E...
Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (B...